{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T05:59:35Z","timestamp":1773554375382,"version":"3.50.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Excellent Young Scholars of Inner Mongolia","award":["2017JQ04"],"award-info":[{"award-number":["2017JQ04"]}]},{"name":"Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region","award":["NJYT-18-B01"],"award-info":[{"award-number":["NJYT-18-B01"]}]},{"name":"Heilongjiang Postdoctoral Research Startup Foundation","award":["LBH-Q19118"],"award-info":[{"award-number":["LBH-Q19118"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61702290"],"award-info":[{"award-number":["61702290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61602135"],"award-info":[{"award-number":["61602135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harbin Medical University Scientific Research Innovation Fund","award":["31041190063"],"award-info":[{"award-number":["31041190063"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Breast cancer is one of the most human malignant diseases and the leading cause of cancer-related death in the world. However, the prognostic and therapeutic benefits of breast cancer patients cannot be predicted accurately by the current stratifying system. In this study, an immune-related prognostic score was established in 22 breast cancer cohorts with a total of 6415 samples. An extensive immunogenomic analysis was conducted to explore the relationships between immune score, prognostic significance, infiltrating immune cells, cancer genotypes and potential immune escape mechanisms. Our analysis revealed that this immune score was a promising biomarker for estimating overall survival in breast cancer. This immune score was associated with important immunophenotypic factors, such as immune escape and mutation load. Further analysis revealed that patients with high immune scores exhibited therapeutic benefits from chemotherapy and immunotherapy. Based on these results, we can conclude that this immune score may be a useful tool for overall survival prediction and treatment guidance for patients with breast cancer.<\/jats:p>","DOI":"10.1093\/bib\/bbaa026","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T12:11:47Z","timestamp":1581941507000},"page":"2020-2031","source":"Crossref","is-referenced-by-count":115,"title":["Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer"],"prefix":"10.1093","volume":"22","author":[{"given":"Shiyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-7835","authenticated-orcid":false,"given":"Yongchun","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"2021070817464226800_ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2021070817464226800_ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2021070817464226800_ref3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s13059-014-0431-1","article-title":"Genome-driven integrated classification of breast cancer validated in over 7,500 samples","volume":"15","author":"Ali","year":"2014","journal-title":"Genome Biol"},{"key":"2021070817464226800_ref4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"2021070817464226800_ref5","doi-asserted-by":"crossref","first-page":"e1002309","DOI":"10.1371\/journal.pmed.1002309","article-title":"Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis","volume":"14","author":"Snyder","year":"2017","journal-title":"PLoS Med"},{"key":"2021070817464226800_ref6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res"},{"key":"2021070817464226800_ref7","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"2021070817464226800_ref8","doi-asserted-by":"crossref","first-page":"e54029","DOI":"10.1371\/journal.pone.0054029","article-title":"Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"2021070817464226800_ref9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"New Engl J Med"},{"key":"2021070817464226800_ref10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1039\/C8MO00128F","article-title":"Clinical significance of the immune microenvironment in ovarian cancer patients","volume":"14","author":"Yang","year":"2018","journal-title":"Mol Omics"},{"key":"2021070817464226800_ref11","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ygeno.2019.08.021","article-title":"Identifying FL11 subtype by characterizing tumor immune microenvironment in prostate adenocarcinoma via Chou's 5-steps rule","volume":"112","author":"Yang","year":"2019","journal-title":"Genomics"},{"key":"2021070817464226800_ref12","first-page":"97","article-title":"Regulation of tumor metastasis by myeloid-derived suppressor cells","volume":"66","author":"Condamine","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"2021070817464226800_ref13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"2021070817464226800_ref14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"2021070817464226800_ref15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"2021070817464226800_ref16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"2021070817464226800_ref17","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2021070817464226800_ref18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2021070817464226800_ref19","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1093\/bioinformatics\/btv377","article-title":"Alternative preprocessing of RNA-sequencing data in the cancer genome atlas leads to improved analysis results","volume":"31","author":"Rahman","year":"2015","journal-title":"Bioinformatics"},{"key":"2021070817464226800_ref20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"2021070817464226800_ref21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2021070817464226800_ref22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"2021070817464226800_ref23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures","volume":"17","author":"\u015eenbabao\u011flu","year":"2016","journal-title":"Genome Biol"},{"key":"2021070817464226800_ref24","doi-asserted-by":"crossref","first-page":"e88309","DOI":"10.1371\/journal.pone.0088309","article-title":"Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity","volume":"9","author":"Wolf","year":"2014","journal-title":"PLoS One"},{"key":"2021070817464226800_ref25","doi-asserted-by":"crossref","first-page":"e1002920","DOI":"10.1371\/journal.pcbi.1002920","article-title":"Biomolecular events in cancer revealed by attractor metagenes","volume":"9","author":"Cheng","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"2021070817464226800_ref26","doi-asserted-by":"crossref","first-page":"181ra150","DOI":"10.1126\/scitranslmed.3005974","article-title":"Development of a prognostic model for breast cancer survival in an open challenge environment","volume":"5","author":"Cheng","year":"2013","journal-title":"Sci Transl Med"},{"key":"2021070817464226800_ref27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"2021070817464226800_ref28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"2021070817464226800_ref29","first-page":"3","article-title":"Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures","volume":"4","author":"Fan","year":"2011","journal-title":"BMC Med Genet"},{"key":"2021070817464226800_ref30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2164-7-115","article-title":"Cell-type specific gene expression profiles of leukocytes in human peripheral blood","volume":"7","author":"Palmer","year":"2006","journal-title":"BMC Genomics"},{"key":"2021070817464226800_ref31","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-13-3368","article-title":"Prognostic B-cell signatures using mRNA-Seq in patients with subtype-specific breast and ovarian cancer","volume":"20","author":"Iglesia","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2021070817464226800_ref32","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1158\/0008-5472.CAN-07-5206","article-title":"The humoral immune system has a key prognostic impact in node-negative breast cancer","volume":"68","author":"Schmidt","year":"2008","journal-title":"Cancer Res"},{"key":"2021070817464226800_ref33","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/bcr3035","article-title":"A clinically relevant gene signature in triple negative and basal-like breast cancer","volume":"13","author":"Rody","year":"2011","journal-title":"Breast Cancer Res"},{"key":"2021070817464226800_ref34","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr2234","article-title":"T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers","volume":"11","author":"Rody","year":"2009","journal-title":"Breast Cancer Res"},{"key":"2021070817464226800_ref35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/1078-0432.CCR-08-1283","article-title":"The macrophage colony-stimulating factor 1 response signature in breast carcinoma","volume":"15","author":"Beck","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2021070817464226800_ref36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.coi.2016.02.001","article-title":"Disentangling the relationship between tumor genetic programs and immune responsiveness","volume":"39","author":"Bedognetti","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"2021070817464226800_ref37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.immuni.2013.07.008","article-title":"The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures","volume":"39","author":"Galon","year":"2013","journal-title":"Immunity"},{"key":"2021070817464226800_ref38","doi-asserted-by":"crossref","first-page":"e1253654","DOI":"10.1080\/2162402X.2016.1253654","article-title":"Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis","volume":"6","author":"Hendrickx","year":"2017","journal-title":"Oncoimmunology"},{"key":"2021070817464226800_ref39","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"2021070817464226800_ref40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney Michael","year":"2015","journal-title":"Cell"},{"key":"2021070817464226800_ref41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2013.06.004","article-title":"A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis","volume":"24","author":"Masiero","year":"2013","journal-title":"Cancer Cell"},{"key":"2021070817464226800_ref42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"2021070817464226800_ref43","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-18-3524","article-title":"Multi-omics profiling reveals distinct microenvironment characterization and suggests immune escape mechanisms of triple-negative breast cancer","volume":"25","author":"Xiao","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2021070817464226800_ref44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez Vega","year":"2018","journal-title":"Cell"},{"key":"2021070817464226800_ref45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/2326-6066.CIR-18-0822","article-title":"Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival","volume":"7","author":"Danilova","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"2021070817464226800_ref46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2021070817464226800_ref47","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2021070817464226800_ref48","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"2021070817464226800_ref49","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.csbj.2019.09.002","article-title":"The spatial binding model of the pioneer factor Oct4 with its target genes during cell reprogramming","volume":"17","author":"Li","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"2021070817464226800_ref50","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1109\/ACCESS.2018.2889809","article-title":"Transcriptome comparisons of multi-species identify differential genome activation of mammals embryogenesis","volume":"7","author":"Long","year":"2018","journal-title":"IEEE Access"},{"key":"2021070817464226800_ref51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/annonc\/mdx755","article-title":"Comprehensive analysis of the clinical immuno-oncology landscape","volume":"29","author":"Tang","year":"2017","journal-title":"Ann Oncol"},{"key":"2021070817464226800_ref52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/intimm\/dxw014","article-title":"Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment","volume":"28","author":"Spranger","year":"2016","journal-title":"Int Immunol"},{"key":"2021070817464226800_ref53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"2021070817464226800_ref54","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"2021070817464226800_ref55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ab.2014.04.032","article-title":"Predicting peroxidase subcellular location by hybridizing different descriptors of Chou\u2019 pseudo amino acid patterns","volume":"458","author":"Zuo","year":"2014","journal-title":"Anal Biochem"},{"key":"2021070817464226800_ref56","doi-asserted-by":"crossref","first-page":"baz131","DOI":"10.1093\/database\/baz131","article-title":"RAACBook: a web server of reduced amino acid alphabet for sequence-dependent inference by using Chou\u2019s five-step rule","volume":"2019","author":"Zheng","year":"2019","journal-title":"Database"},{"key":"2021070817464226800_ref57","first-page":"1316","article-title":"Identifying sigma70 promoters with novel pseudo nucleotide composition","volume":"6","author":"Lin","year":"2017","journal-title":"Trans Comput Biol Bioinform"},{"key":"2021070817464226800_ref58","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","article-title":"Tumor infiltrating lymphocytes in ovarian cancer","volume":"16","author":"Santoiemma","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"2021070817464226800_ref59","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"2021070817464226800_ref60","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"2021070817464226800_ref61","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2021070817464226800_ref62","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"key":"2021070817464226800_ref63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/djx213","article-title":"Immune activation and benefit from avelumab in EBV-positive gastric cancer","volume":"110","author":"Panda","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"2021070817464226800_ref64","doi-asserted-by":"crossref","first-page":"eaah3560","DOI":"10.1126\/scitranslmed.aah3560","article-title":"Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance","volume":"9","author":"Roh","year":"2017","journal-title":"Sci Transl Med"},{"key":"2021070817464226800_ref65","doi-asserted-by":"crossref","first-page":"e180013","DOI":"10.1001\/jamaoncol.2018.0013","article-title":"Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial","volume":"4","author":"Fuchs","year":"2018","journal-title":"JAMA Oncol"},{"key":"2021070817464226800_ref66","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41467-017-01018-0","article-title":"Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers","volume":"8","author":"Ock","year":"2017","journal-title":"Nat Commun"},{"key":"2021070817464226800_ref67","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/2020\/36670086\/bbaa026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/2020\/36670086\/bbaa026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T01:22:24Z","timestamp":1625793744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/22\/2\/2020\/5788231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa026","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,3,6]]}}}